…tes with overall cancer (1.15 (1.06 to 1.25); 14.3%, 12.2%) and breast cancer (1.25 (1.07 to 1.45); 6.1%, 4.9%); acetic acid with overall can…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 57 of 2459…Background Cardiovascular diseases, overweight, type 2 diabetes and chronic kidney disease increase the risk of cardiovascular …
…and the Ankylosing Spondylitis Disease Activity Score with CRP (ASDAS-CRP) for axSpA, alongside patient-reported outcomes (PROs).Results …
Proteomic analysis reveals angiogenesis-related plasma proteins associated with pre-eclampsia in SLE
…, endostatin and angiogenin, respectively, and pre-eclampsia in SLE. Given the consistent elevation of endostatin throughout pregna…
…es, especially B-cell malignancies. The risk is highest in men. Myeloid malignancies tend to present closer to SSc diagnosis than lymphoid malignanc…
…ation-induced cells death.Conclusions ICT01 in combination with pembrolizumab generated clinically meaningful anti-tumor efficacy in 2L CPI-r…
…Background Cervical cancer is one of the leading causes of cancer-related mortality among …
…Background Ovarian cancer has a five-year relative survival rate of 50.9%, making it the …
…y signals. These preliminary data support further evaluation of ruxolitinib as an adjunctive therapy for severe CIP. ClinicalTrials.gov Ide…
…cranial samples were 57% (16/28) with 22C3 and 61% (17/28) with SP263. For 24 patients receiving intrathecal immunotherapy, the corre…
…responses were associated with favorable clinical outcomes with ipilimumab.4 Tertiary lymphoid structures (TLS) are aggregates of T cells,…
…Background Neuroblastoma is the most common and deadly extracranial pediatric tumor, acc…